Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

TBI Based Conditioning Regimen and Intra Osseous Application of PBSC to Overcome Graft Resistance In a Patient with Autoimmune Lymphoproliferative Syndrome (ALPS)

Daniel Stachel, MD, Nora Naumann-Bartsch, MD, Patrick Morhart, MD, Markus Metzler, MD, Thorsten Langer, MD, Klaus Schwarz, Wolfgang Holter, MD

Blood (2010) 116 (21): 4696.

https://doi.org/10.1182/blood.V116.21.4696.4696

Published: 2010

Journal Articles

Pbx-1 Is a Direct Target of Evi-1 in Hematopoietic Stem/Progenitors and Leukemic Cells.

Munetake Shimabe, Susumu Goyama, MD, PhD, Motoshi Ichikawa, MD, PhD, Yoichi Imai, MD, PhD, Tsuyoshi Takahashi, MD, PhD, Akira Hangaishi, MD, PhD, Mineo Kurokawa, MD, PhD

Blood (2008) 112 (11): 1192.

https://doi.org/10.1182/blood.V112.11.1192.1192

Published: 2008

Journal Articles

Post-Transcriptional Regulation of Tissue Factor Expression in Human Monocytic Cells: Identification of Novel Exonic Splicing Enhancers for the Spliceosomal Protein SRp40 and Intronic Elements Critical for Exon 5 Definition

Sajiv Chandradas, BA, Jonathan G Tardos, MD, Ke Jiang, MSc, Vladimir Bogdanov, PhD

Blood (2008) 112 (11): 1031.

https://doi.org/10.1182/blood.V112.11.1031.1031

Published: 2008

Journal Articles

Molecular Dissection of Human Tissue Factor Pre-mRNA Processing: Identification and Characterization of Functional Exonic Splicing Enhancers in Variable Exon 5.

Jonathan G. Tardos, Vladimir Y. Bogdanov, PhD

Blood (2006) 108 (11): 1748.

https://doi.org/10.1182/blood.V108.11.1748.1748

Published: 2006

Journal Articles

Short Nucleotide Insertions in the MCL-1 Promoter Affect Its Gene Expression.

Oksana Moshynska, PhD, Igor Moshynskyy, PhD, Mark Bosch, Tania Qureshi, Anurag Saxena, MD

Blood (2005) 106 (11): 4371.

https://doi.org/10.1182/blood.V106.11.4371.4371

Published: 2005

NARROW

TBI Based Conditioning Regimen and Intra Osseous Application of PBSC to Overcome Graft Resistance In a Patient with Autoimmune Lymphoproliferative Syndrome (ALPS)

Pbx-1 Is a Direct Target of Evi-1 in Hematopoietic Stem/Progenitors and Leukemic Cells.

Post-Transcriptional Regulation of Tissue Factor Expression in Human Monocytic Cells: Identification of Novel Exonic Splicing Enhancers for the Spliceosomal Protein SRp40 and Intronic Elements Critical for Exon 5 Definition

Molecular Dissection of Human Tissue Factor Pre-mRNA Processing: Identification and Characterization of Functional Exonic Splicing Enhancers in Variable Exon 5.

Short Nucleotide Insertions in the MCL-1 Promoter Affect Its Gene Expression.

Email alerts

ASH Publications

American Society of Hematology

TBI Based Conditioning Regimen and Intra Osseous Application of PBSC to Overcome Graft Resistance In a Patient with Autoimmune Lymphoproliferative Syndrome (ALPS)

Pbx-1 Is a Direct Target of Evi-1 in Hematopoietic Stem/Progenitors and Leukemic Cells.

Post-Transcriptional Regulation of Tissue Factor Expression in Human Monocytic Cells: Identification of Novel Exonic Splicing Enhancers for the Spliceosomal Protein SRp40 and Intronic Elements Critical for Exon 5 Definition

Molecular Dissection of Human Tissue Factor Pre-mRNA Processing: Identification and Characterization of Functional Exonic Splicing Enhancers in Variable Exon 5.

Short Nucleotide Insertions in the MCL-1 Promoter Affect Its Gene Expression.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only